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Dietary restriction (DR) without malnutrition encom-
passes numerous regimens with overlapping bene-
fits including longevity and stress resistance, but uni-
fying nutritional and molecular mechanisms remain
elusive. In a mouse model of DR-mediated stress
resistance, we found that sulfur amino acid (SAA)
restriction increased expression of the transsulfura-
tion pathway (TSP) enzyme cystathionine g-lyase
(CGL), resulting in increased hydrogen sulfide (H2S)
production and protection from hepatic ischemia
reperfusion injury. SAA supplementation, mTORC1
activation, or chemical/genetic CGL inhibition
reduced H2S production and blocked DR-mediated
stress resistance. In vitro, the mitochondrial protein
SQR was required for H2S-mediated protection dur-
ing nutrient/oxygen deprivation. Finally, TSP-depen-
dent H2S production was observed in yeast, worm,
fruit fly, and rodentmodels ofDR-mediated longevity.
Together, these data are consistent with evolutionary
conservation of TSP-mediated H2S as a mediator
of DR benefits with broad implications for clinical
translation.
INTRODUCTION
Dietary restriction (DR) encompasses a variety of nutritional
interventions with overlapping functional benefits including
increased stress resistance and extended longevity in a number
of organisms across evolutionary boundaries (Fontana et al.,
2010). In mammals, dietary regimens associated with these ben-
efits are diverse, including reduced daily food intake, intermittent
fasting and reduced protein or essential amino acid intake.
Although common features exist among DR regimens, including
reduced adiposity and improved sensitivity to growth factors,
differences exist as well. Thus, whether overlapping functional
benefits of DR regimens share a common underlying nutritional132 Cell 160, 132–144, January 15, 2015 ª2015 Elsevier Inc.and/or molecular basis remains unclear. Despite strong evi-
dence of DR benefits in humans (Levine et al., 2014), difficulties
with compliance prevent widespread clinical applications. Un-
covering common mechanisms is thus of great significance for
targeted dietary and/or pharmacological interventions.
Mitohormesis represents a potential unifying molecular hy-
pothesis of DR action (Sinclair, 2005). Based on the concept of
hormesis (Calabrese and Mattson, 2011), in which low-level
stressors promote adaptive changes resulting in stress resis-
tance, the mitohormesis hypothesis of DR posits that increased
reactive oxygen and nitrogen species (RONS) derived from
increased mitochondrial fatty acid oxidation induce mild oxida-
tive stress, thus driving adaptive mechanisms of antioxidant pro-
tection (Tapia, 2006). SKN1/NRF2 has emerged as a candidate
mediator of adaptive protection based on its activation by
RONS and function as a key transcription factor in the cytopro-
tective phase II antioxidant and detoxification response (Hine
andMitchell, 2012). Gene targets of NRF2 include heme oxygen-
ase-1 (HO-1), NAD(P)H dehydrogenase quinone 1 (NQO-1),
glutathione transferases (GSTs), and additional genes that utilize
glutathione (GSH) for resolving oxidative stress. SKN1/NRF2 in
worms is required for stress resistance and longevity benefits
of DR (Bishop and Guarente, 2007). In mammals, NRF2 is
required for DR-mediated protection from chemically induced
carcinogenesis but not for DR-mediated longevity (Pearson
et al., 2008). Functionally, mitohormesis can be blocked by
vitaminC, vitamin E, and/or N-acetyl cysteine (NAC), presumably
due to their antioxidant capacity (Ristow and Schmeisser, 2011).
Restriction of sulfur amino acids (SAAs) methionine (Met) and
cysteine (Cys) is common to numerous DR regimens across
evolutionary boundaries and is thus a potential shared nutritional
trigger of DR benefits. In yeast, Met restriction extends longevity
(Ruckenstuhl et al., 2014). In flies, restriction of essential amino
acids (EAAs), and in particular Met, controls DR longevity bene-
fits (Grandison et al., 2009). Dietary Met further interacts with
overall protein levels in longevity control (Lee et al., 2014). In
rodents, diets lacking the nonessential amino acid (NEAA) Cys
and restricted for Met (Met restriction, or MetR) extend longevity
and increase hepatic stress resistance (Miller et al., 2005; Oren-
treich et al., 1993).
The TSP controls the conversion of Met into Cys and is
required for DR-mediated lifespan extension in flies (Kabil
et al., 2011a). Two key enzymes of this evolutionarily conserved
pathway are cystathionine b-synthase (CBS) and cystathionine
g-lyase (CGL). Under normal physiological conditions, CBS con-
verts serine and homocysteine, a product of Met methyl transfer,
into cystathionine. Cystathionine is then converted into a-keto-
butyrate and Cys by CGL (Kabil et al., 2011b). Although Cys is
required for de novo synthesis of GSH, thus potentially linking
TSP to NRF2-mediated antioxidant responses, the molecular
mechanism underlying the genetic requirement for a functional
TSP in DR-mediated benefits is unknown.
A product of the TSP with potential to mediate physiological
benefits including stress resistance and extended longevity is
the water and fat-soluble gas H2S (Cuevasanta et al., 2012;
Zhang et al., 2013). Although toxic at high levels, H2S produced
at low concentrations by degradation of Cys or homocysteine by
CGL or CBS acts on the vasculature and the brain as a signaling
molecule to reduce blood pressure (Yang et al., 2008) and pre-
vent neurodegeneration (Paul and Snyder, 2012). Exogenous
H2S can also extend lifespan of worms (Miller and Roth, 2007)
and induce suspended animation in mammals (Blackstone
et al., 2005). Although diet can impact H2S production (Predmore
et al., 2010), neither the dietary requirements for increased
endogenous H2S production, nor the potential role of H2S in
the benefits of DR are currently known.
Ischemia reperfusion injury (IRI) is initiated by lack of nutrients
and oxygen due to occlusion of blood flow (ischemia) followed by
activation of pro-oxidation pathways and inflammatory media-
tors in damaged tissues upon return of blood flow (reperfusion).
IRI represents a major clinical concern in controlled (tissue
resection, organ transplantation) and uncontrolled settings
(stroke, heart attack). Various short-term (3–14 days) DR regi-
mens improve outcome in models of kidney, liver, and brain IRI
(Harputlugil et al., 2014; Mitchell et al., 2010; Peng et al., 2012;
Varendi et al., 2014). Here, we used dietary preconditioning
against hepatic IRI as a model system to probe dietary and mo-
lecular mechanisms underlying protection.
RESULTS
NAC, but Not NRF2Deficiency, Abrogates Benefits of DR
against IRI
Fifty percent DR for 7 days significantly decreased body weight,
percentage fat mass, serum triglycerides (TGs) (Figures 1A–1C),
and blood glucose (BG) (Figure S1A available online) while
increasing hepatic expression of FAO-related genes (Figure 1D)
and the rate of peroxisomal FAO (Figure 1E) relative to the ad
libitum (AL)-fed group. Consistent with themitohormesis hypoth-
esis, hepatic RONS and NRF2 target gene expression were
increased (Figures 1F and 1G), and the latter blocked by NAC
administration during the DR period. Total GSH was also
decreased upon DR (Figure 1H).
The functional relevance of increased RONS and NRF2 activa-
tion in DR-mediated stress resistance was tested in a model of
hepatic IRI. Wild-type (WT) mice were preconditioned on AL or
DR regimens ± NAC for 1 week prior to IRI. NAC treatment
was halted 24 hr prior to IRI to avoid any direct antioxidant ef-fects of this short-lived compound on outcome. Neither DR nor
NAC had any significant effect on liver damagemarkers in serum
prior to IRI (data not shown). After reperfusion, liver damage
markers remained significantly lower in DR serum indicative of
protection from injury (Figure 1I). NAC had no effect on outcome
in the AL group, but significantly reduced protection in the DR
group. Macroscopic and histological analysis of hemorrhagic
necrosis in livers excised 24 hr after reperfusion (Figure 1J; Fig-
ure S1B) was consistent with serum damage markers (Figure 1I).
To test the requirement for the NRF2-dependent phase II anti-
oxidant response, we compared NRF2 knockout (KO) mice to
wild-type (WT) littermate controls. NRF2KO mice subjected to
DR had decreased hepatic GSH similar to WT (Figure S1C) but
failed to upregulate phase II antioxidant response genes as ex-
pected (Figure S1D). Surprisingly, benefits of DR against hepatic
IRI did not require NRF2, with similar reductions in liver damage
markers in serum (Figure 1K) andmacroscopic evidence of hem-
orrhage 24 hr postreperfusion upon DR in both WT and NRF2KO
mice (Figure S1E). To confirm and extend this result, we tested
the requirement for NRF2 in DR-mediated protection from renal
IRI. Although AL-fed NRF2KOs had slightly elevated damage
and decreased renal function upon IRI relative to WT mice as re-
ported previously (Liu et al., 2009), both gained similar benefits
upon DR (Figure S1F).
Sulfur Amino Acids Control the Benefits of DR and PR
NRF2 independence of DR benefits despite abrogation by NAC
is consistent either with an alternate RONS-dependent mecha-
nism of DR-mediated protection, or an antioxidant-independent
activity of NAC. NAC is also a source of Cys, and NAC supple-
mentation to the DR group above serendipitously returned die-
tary Cys content close to AL levels. To separate the functional
consequences of antioxidant capacity from SAA content, we
supplemented restricted diets separately with either antioxi-
dants (vitamin C and E [VitC&E]) or a 2 3 concentration of Met
and Cys (23Met&Cys) for 1 week prior to hepatic IRI. Following
reperfusion, protection afforded by DR was maintained despite
VitC&E antioxidant treatment, but abrogated by 23Met&Cys
(Figures 2A and 2B) without affecting food intake, weight loss,
or expression of FOXO target genes (Figures S2A–S2C), consis-
tent with the relative importance of the SAA aspect of NAC in
abrogation of DR benefits.
Protein and carbohydrates are isocaloric and partially inter-
convertible as dietary energy sources, rendering distinctions be-
tween calorie restriction and protein/amino acid restriction upon
DR challenging. To test the relative contribution of energy restric-
tion, protein restriction (PR), and specifically SAA restriction to
DR-mediated protection against hepatic IRI, we preconditioned
mice on a complete or isocaloric protein-free diet fed either AL or
35% restricted ± 23Met&Cys. Following hepatic IRI, PR mice
displayed significant protection from liver damage (Figures 2C
and 2D) independent of total calorie intake or weight loss (Fig-
ures S2D and S2E). Importantly, 23Met&Cys abrogated signifi-
cant benefits of combined protein/energy restriction (Figures
2C and 2D) without affecting weight loss (Figure S2E). Because
MetR regimens offering overlapping functional benefits with
DR are also restricted or deficient in Cys, we also tested Cys
reconstitution alone. Following reperfusion, protection observedCell 160, 132–144, January 15, 2015 ª2015 Elsevier Inc. 133
Figure 1. NAC Abrogates Benefits of DR against Acute Stress Independent of NRF2
(A–H) Effects of 1 week of 50% DR versus AL feeding ± NAC as indicated on body weight (n = 15–17/group, A); %fat mass (n = 5/group, B); serum triglycerides
(n = 4–7/group, C); hepatic FAO-associated gene expression (n = 3/group, D); peroxisomal FAO capacity in liver extracts (n = 3/group, E); hepatic RONS (n = 6–8/
group, F); hepatic NRF2 target gene expression (n = 4/group, G); and hepatic GSH levels (n = 7/group, H).
(I and J) Combined serum markers of liver damage normalized to the average of the AL control group (I) and liver pathology from injured left liver lobes on the
microscopic level stained with hematoxylin and eosin (scale bar, 250 mm, above) and the macroscopic level (13magnification, below) showing fixed tissue 24 hr
after reperfusion (J) in mice (n = 5–6/group) preconditioned as indicated before hepatic IRI or mock injury. Asterisk indicates the significance of the difference
between AL and DR, and pound sign between DR and DR + NAC; */#p < 0.05.
(K) Serum markers of liver damage in WT (n = 5–6/group) or NRF2KO (n = 7–12/group) preconditioned as indicated. Asterisk indicates the significance of the
difference between AL and DR within genotype; *p < 0.05.
All error bars SEM. See also Figure S1.in the DR group was abrogated upon 23Cys supplementation
(Figures 2E and 2F), consistent with PR and Cys restriction as
critical aspects of DR-mediated resistance to hepatic IRI.
DR Stimulates Endogenous H2S Production via
Repression of mTORC1 and Activation of the TSP
Expression and activity of TSP genes CBS and CGL increase
when Cys is low (Stipanuk and Ueki, 2011) to allow de novo syn-
thesis fromMet (Figure 3A). Hepatic CGL andCBS to a lesser de-
gree were increased on the mRNA and protein levels upon
1 week DR (Figures 3B and 3C), and this was abrogated by 23
Met&Cys or NAC supplementation (Figure 3B).
Ametabolomics approach was used to identify candidate TSP
metabolites involved in DR-mediated protection. To facilitate134 Cell 160, 132–144, January 15, 2015 ª2015 Elsevier Inc.identification of potentially causative versus correlative changes,
we included a genetic model that fails to gain the benefits of DR
against hepatic IRI due to liver-specific genetic ablation of the
mTORC1 repressor, tuberous sclerosis complex 1 (TSC1) (Har-
putlugil et al., 2014) (Figure 3D; Figure S3A). GSH and taurine
are two downstream metabolites with potential to protect
against IRI, however neither was increased by DR specifically
in WT mice (Figure 3D). A third protective TSP metabolite is
hydrogen sulfide (H2S) (Kang et al., 2009). Although not detected
in our metabolomic screen, associated by-products homoserine
and serine (Kabil et al., 2011b) were significantly increased upon
DR in WT but not TSC1KO livers (Figure 3D).
For direct measurement of H2S, we leveraged the specific re-
action between H2S and lead acetate to form a black precipitate
Figure 2. Sulfur Amino Acids Control the Benefits of DR and PR
(A and B) Serum markers of liver damage (A) and liver pathology after reperfusion (B) in mice (n = 5/group) preconditioned on complete diets fed AL or 50% DR ±
supplementation with vitamins C&E or Met&Cys as indicated. Asterisk indicates the significance of the difference versus AL and pound sign versus DR + 23
Met&Cys; */#p < 0.05.
(C and D) Serum markers of liver damage (C) and liver pathology after reperfusion (D) in mice (n = 5/group) preconditioned on complete (Comp) or protein-free
(Prot. Free) diets fed AL or 35% DR with Met&Cys addition as indicated prior to hepatic IRI. Asterisk indicates the significance of the difference versus AL
complete and pound sign versus DR Prot. Free + Met&Cys; */# p < 0.05.
(E and F) Serummarkers of liver damage (E) and liver pathology after reperfusion (F) in mice (n = 5/group) preconditioned on complete diets fed AL or 50%DRwith
23Cys added as indicated. Asterisk indicates the significance of the difference versus AL and pound sign versus DR + 23Cys; */#p < 0.05.
All error bars SEM. See also Figure S2.(lead sulfide) that can be trapped and visualized on filter paper
containing lead acetate (Figure S3B). In the presence of excess
CGL/CBS substrate Cys and cofactor pyridoxal-50-phosphate
(PLP), H2S gas produced by liver extracts was greater from
DR- than AL-fed mice (Figure 3E). This phenomenon was inde-
pendent of NRF2 status (Figure S3C). Met&Cys add-back during
DR blocked the DR-mediated increase in H2S production
capacity (Figure 3F), correlating with a loss of protection against
hepatic IRI (Figure 2A) and normalization of hepatic GSH levels
(Figure S3D).Using a less specific but more easily quantifiable sulfide
probe-based method calibrated against known H2S concentra-
tions (Figures S3E and S3F), liver extracts of DR mice displayed
a 4-fold increase in H2S production capacity compared to AL
mice (Figure 3G). Endogenous hepatic H2S levels measured by
insertion of the sulfide probe into the right and median lobes of
anesthetized mice were in the low micromolar range relative to
the appropriate standard curve (Figures S3G and S3H), and
nearly 3-fold higher in the livers of DR relative to AL-fed mice
(Figure 3H).Cell 160, 132–144, January 15, 2015 ª2015 Elsevier Inc. 135
Figure 3. DR Stimulates Endogenous H2S Production via the TSP
(A) Model of the transmethylation and TSP. Arrows trace sulfur from Met to Cys and downstream cellular processes via cystathionine beta-synthase (CBS) and
cystathionine gamma-lyase (CGL). Metabolites in green (taurine, GSH and H2S) have demonstrated potential to protect against IRI. MAT, methionine adenosyl
transferase; SAM: S-adenosylmethionine; SAH, S-adenosylhomocysteine; SAHH, S-adenosylhomocysteine hydrolase; MS, methionine synthase; BHMT,
betaine homocysteine methyltransferase.
(B) Hepatic CBS and CGL gene expression upon DR ± 23Met&Cys or NAC as indicated; n = 3/group.
(C) Immunoblots of CGL, CBS, and actin in liver extracts from AL or DR mice as indicated; NS, nonspecific protein band.
(D) Liver metabolites in WT or LTsc1KO mice fed 35% DR on a protein-free diet relative to the AL-fed complete diet group; n = 5/group.
(E and F) H2S production capacity from liver extracts of AL or DR mice (E) ± 23Met&Cys (F) as detected by the black precipitate, lead sulfide.
(G) H2S production capacity as in (E) but using a microsulfide probe to detect H2S.
(H) Endogenous hepatic H2S in mice on the indicated diet using a microsulfide probe inserted into liver lobes; n = 3 mice/group, two lobes/mouse. Asterisk
indicates the significance of the difference versus AL; *p < 0.05.
(I and J) Immunoblots of liver CGL (I) and H2S production (J) in WT and LTsc1KO mice fed AL or 35% DR on a protein-free diet.
All error bars SEM. See also Figure S3.Consistent with a link between DR, TSP, H2S, and protection
from IRI, DR failed to increase hepatic CGL protein and H2S pro-
duction capacity in livers of TSC1KO mice (Figures 3I and 3J),
suggesting that constitutive mTORC1 activation blocks DR-
mediated TSP upregulation.
H2S Is Necessary and Sufficient to Confer DR-Mediated
Stress Resistance In Vivo
We next determined if exogenous H2S is sufficient to confer pro-
tection in our model of hepatic IRI. AL-fed mice injected with the
H2S precursor NaHS or vehicle 30 min prior to ischemia had136 Cell 160, 132–144, January 15, 2015 ª2015 Elsevier Inc.decreased liver damage relative to vehicle-treated controls (Fig-
ures 4A and 4B). Similarly, noninvasive H2S delivery in the drink-
ing water for 1 week prior to hepatic IRI using the slow releasing/
long-lived donor GYY4137 (Lee et al., 2011) (but not the fast
releasing/short-lived donor NaHS) decreased liver damage
without affecting animal weight, food intake, or water consump-
tion (Figures S4A–S4D). Thus, exogenous H2S is sufficient to
protect against hepatic IRI.
A specific inhibitor of CGL, DL-propargylglycine (PAG), was
employed to determine if endogenous H2S is necessary for
DR-mediated stress resistance. PAG treatment blocked hepatic
Figure 4. H2S Is Necessary and Sufficient to Confer DR Benefits against Hepatic IRI
(A and B) Serum markers of liver damage (A) and liver pathology after reperfusion (B) in mice (n = 4–5/group) treated with vehicle or H2S 30 min prior to surgery.
Asterisk indicates the significance of the difference versus AL; *p < 0.05.
(C and D) Serum markers of liver damage (C) and liver pathology after reperfusion (D) in mice (n = 3–4/group) treated with PAG during AL or DR preconditioning
with a single H2S injection prior to surgery as indicated. Asterisk indicates the significance of the difference versus AL and pound sign versus DR + PAG;
*/#p < 0.05.
(E) Immunoblot of CGL in liver extracts of WT or CGLKO mice as indicated. NS, nonspecific protein.
(F) H2S production capacity of liver extracts from WT or CGLKO mice preconditioned as indicated.
(G and H) Serum markers of liver injury (G) and liver pathology after reperfusion (H) in WT or CGLKO mice (n = 5–8/group) preconditioned as indicated. Asterisk
indicates the significance of the difference versus WT AL and pound sign versus CGLKO DR; */#p < 0.05.
(I) Immunoblot of CGL in liver extracts fromWTmice infected with control (Ad Null) or CGL-overexpressing (Ad-CGL) adenovirus as indicated; NS LC, nonspecific
loading control protein.
(J) H2S production capacity of liver extracts of Ad-Null- or Ad-CGL-infected mice.
(K and L) Serum markers of liver damage (K) and liver pathology after reperfusion (L) in Ad-Null- or Ad-CGL-infected mice (n = 6/group). Asterisk indicates the
significance of the difference versus Ad Null; *p < 0.05.
All error bars SEM. See also Figure S4.H2S production capacity (Figure S4E) and decreased endoge-
nous hepatic H2S levels upon DR (Figure S4F), consistent with
the dominant role of CGL in hepatic H2S production. PAG treat-
ment had no effect on IRI outcome in AL mice but abrogated
benefits of DR (Figures 4C and 4D). Readdition of H2S via IP
injection of 30 min prior to induction of ischemia in DR +
PAG-treated mice restored protection (Figures 4C and 4D).
Two genetic models were used to test the specificity of the
TSP and H2S in protection against hepatic IRI (Figures 4E–4L).
The necessity of CGL in DR-mediated benefits was tested with
whole-body CGLKO mice (Yang et al., 2008). CGLKO mice re-
sponded to DR like WT mice with respect to changes in body
weight, food intake, body composition, and blood glucose (Fig-ures S4G–S4J) despite the lack of CGL protein in liver or capacity
of liver extracts to produce H2S (Figures 4E and 4F). However,
whereas the absence of CGL had no apparent impact on the
outcome of hepatic IRI in AL-fed mice, CGLKO mice failed to
gain protection upon DR (Figures 4G and 4H). To test the suffi-
ciency of increased TSP activity and endogenous H2S produc-
tion, CGL was overexpressed via adenoviral-mediated gene
delivery (Ad-CGL). Hepatic CGL protein levels and H2S produc-
tion capacity were both significantly increased (Figures 4I and
4J) independent of body mass or food intake relative to control
adenovirus (Ad Null) -infected mice (Figures S4K and S4L). Ad-
CGL infection resulted in improved outcome after hepatic IRI
relative to Ad-Null-infected mice (Figures 4K and 4L). Together,Cell 160, 132–144, January 15, 2015 ª2015 Elsevier Inc. 137
these results suggest that increased TSP activity and endoge-
nous H2S production via CGL are sufficient and, in the case of
DR, necessary for protection against the acute surgical stress
of hepatic IRI.
H2S Is Necessary and Sufficient to Confer DR-Mediated
Stress Resistance In Vitro via Sulfhydration and
Antioxidant Properties
To determine if TSP gene expression and H2S production can be
induced in a cell-autonomous manner by SAA restriction, we
cultured mouse hepatocyte-derived Hepa1-6 cells overnight in
complete media or media lacking SAA (–Met&Cys). Similar to
DR in vivo, SAA deprivation increased CBS and CGL expression
and H2S production capacity in vitro (Figures 5A and 5B).
To determine if exogenously added H2S can protect cultured
Hepa1-6 cells against simulated IRI, warm ischemia was simu-
lated by replacing growth media with saline and incubating in a
37C hypoxic chamber for up to 4 hr, and reperfusion by replac-
ing the growth media under normoxic conditions. Addition of
H2S decreased Hepa1-6 cell damage under both normoxic
and hypoxic conditions during the ischemic phase (Figure 5C)
and restored MTT activity during the reperfusion phase (Fig-
ure 5D), indicating that exogenous H2S is sufficient to induce sig-
nificant protection against both nutrient/energy deprivation and
hypoxia in vitro.
To assess if endogenous H2S induced by SAA restriction af-
forded similar protection, primary hepatocytes were cultured ±
Met&Cys overnight prior to simulated IRI. LDH release
during ischemia was decreased (Figure 5E), and MTT activity
during reperfusion increased in hepatocytes preconditioned in
Met&Cys-deficient media (Figure 5F). Similar protection afforded
by overnight preconditioning of Hepa1-6 cells in -Met&Cys me-
dia was blocked by addition of PAG during the preconditioning
period and was partially rescued by exogenous addition of H2S
during ischemia (Figure S5A).
H2S has been proposed to prevent cell damage/death under
stress in part by sulfhydration of target proteins (Paul and
Snyder, 2012) including the mitochondrial inner membrane
component sulfide quinone oxidoreductase (SQR), which allows
transfer of electrons from H2S to coenzyme Q and the electron
transport chain (ETC) (Mo´dis et al., 2013; Olson et al., 2013) (Fig-
ure 5G). To test the potential role of the SQR in H2S-mediated
protection, we partially knocked down the SQR in Hepa1-6 cells
(Figure S5B) prior to simulated IRI ± exogenous H2S. H2S addi-
tion reduced LDH release during the ischemic phase and upon
reperfusion (Figures 5H and 5I); the latter was significantly
altered upon SQR knockdown (KD) (Figure 5I). Additionally, the
increase in MTT activity during the reperfusion phase in the pres-
ence of H2S was significantly reduced by SQR KD (Figure 5J).
SQR KD did not significantly alter the effects of H2S addition
on nutrient/growth factor withdrawal in the absence of hypoxia
(Figures 5H–5J).
Because oxidation of H2S by SQR results in production of thio-
sulfate (S2O3
2) (Hildebrandt and Grieshaber, 2008), which itself
can be utilized in mammalian tissues under hypoxic conditions
for further H2S production (Olson et al., 2013), we next tested if
this downstream metabolite could afford similar protection
against simulated IRI in Hepa1-6 cells. Although thiosulfate138 Cell 160, 132–144, January 15, 2015 ª2015 Elsevier Inc.had a negative impact on LDH release upon nutrient/growth
factor withdrawal under normoxia, increasing thiosulfate con-
centrations decreased cell damage during the ischemic phase
under hypoxia (Figure S5C) and improved MTT activity during
the reperfusion phase (Figure S5D). SQR KD partially blocked
thiosulfate-mediated protection against simulated IRI (Fig-
ure 5K; Figure S5E), suggesting that the protective effect of
thiosulfate during hypoxia can be partially attributed to its con-
version to H2S.
H2S also has antioxidant properties (Calvert et al., 2010) that
could contribute to cytoprotection independent of target protein
sulfhydration. At 100 mM but not 10 mM final concentration, H2S
protected Hepa1-6 cells against acute oxidative stress delivered
by H2O2 exposure (Figures S5F and S5G). Similar protection
was found with 100 mM H2S against H2O2 exposure in primary
smooth muscle cells (Figures S5H and S5I). Thus, H2S protects
from acute ischemic insult and oxidative stress via multiple
mechanisms.
Increased Endogenous H2S Production in Diet-Induced
Longevity Extension Models across Evolutionary
Boundaries
Although exogenous H2S can extend longevity in worms, the
potential role of endogenousH2S in DR-mediated lifespan exten-
sion has not been reported. To test the hypothesis that increased
endogenous H2S is a common feature of DR regimens that
lead to extended longevity across evolutionary boundaries, we
measured H2S production capacity in four different organisms
subjected to species-appropriate DR longevity regimens.
Adult mice subjected to long-term MetR (Figure 6A), EOD
fasting, or 20%–30% DR (Figure 6B) had increased H2S produc-
tion capacity in liver and kidney extracts compared to AL-fed
complete diet controls. In mice subjected to 1 week 50% DR,
kidney, spleen, and carotid artery additionally demonstrated
increased H2S production capacity (Figure S6A), whereas brain,
skeletal muscle, heart, and aorta tested under the same condi-
tions did not (Figure S6B). Nonetheless, primary smooth muscle
cells prepared from aorta displayed increased H2S production
capacity upon Met&Cys depletion (Figure S6C), suggesting tis-
sue/cell type specificity in the regulation of the TSP in response
to diet. Although we failed to observe an increase in H2S
production capacity in mouse brain upon 1 week 50% DR,
3 days of water-only fasting increased H2S production capacity
(Figure S6D).
In the fruit fly D. melanogaster, maximal H2S production ca-
pacity of whole-body extracts of flies subjected to varying levels
of dietary protein and Met restriction (Figure 6C) correlated with
maximal lifespan extension (Lee et al., 2014).
In the nematode worm C. elegans, the eat-2mutant serves as
a genetic model of lifespan extension by DR due to defects in
pharyngeal function resulting in decreased food intake (Lakow-
ski and Hekimi, 1998). Extracts of eat-2 mutants produced
more H2S than extracts of age-matched WT N2 worms (Fig-
ure 6D). To assess the genetic requirements for TSP factors in
longevity extension, we performed individual RNAi-mediated
KD of the two worm CGL homologs CTH-1 and CTH-2, the
CBS homolog CBS-1, and a fourth worm TSP gene, CBL-1. Indi-
vidual RNAi KD of CBL-1 and CBS-1 had no effect on longevity
Figure 5. Mitochondrial SQR Is Required for Cytoprotective Effects of H2S during Ischemia
(A and B) Cell-autonomous increase in TSP enzymes and H2S production. (A) CBS and CGL gene expression in Hepa1-6 cells cultured overnight in complete or -
Met&Cys media. Asterisk indicates the significance of the difference versus complete; *p < 0.05. (B) H2S production in live Hepa1-6 cells preconditioned in
complete or -Met&Cys media in quadruplicate for 16–24 hr as indicated before readdition of Cys and PLP for H2S detection.
(C and D) Cell-autonomous effects of exogenous H2S on simulated IRI in Hepa1-6 cells in vitro; H2S was added during the ischemic phase and removed upon
simulated reperfusion. (C) LDH release during the ischemic phase consisting of 3 hr incubation in saline (simulated nutrient/energy deprivation) under normoxic or
hypoxic (simulated ischemia) conditions ± exogenous H2S as indicated. (D) MTT activity during the reperfusion phase consisting of readdition of complete media
under normoxic conditions (simulated reperfusion).
(E and F) Cell-autonomous effects of overnight Met&Cys withdrawal (preconditioning phase conditions) on simulated IRI in primary hepatocyes in vitro. LDH
release (E) during simulated ischemia and MTT activity (F) upon simulated reperfusion.
(G) Schematic of H2S oxidation to thiosulfate by SQR in mitochondria. Q, coenzyme Q; IMS, inner membrane space; I and II, complex I and II of the mitochondrial
ETC; SD, sulfur dioxygenase; ST, sulfur transferase; S2O3
2, thiosulfate.
(H–J) Effects of exogenous H2S on simulated IRI upon SQRKD in Hepa1-6 cells. LDH release during the ischemic phase (H) in saline under the indicated normoxic
or hypoxic conditions ± SQR KD, and during the reperfusion phase (I) in complete media expressed relative to respective group not receiving H2S during the
ischemic phase; and MTT activity (J) during the reperfusion phase. Asterisk indicates the significance of the difference in the indicated group ± H2S treatment;
hash mark indicates the significance of the difference between control and SQR KD within a given treatment group; */#p < 0.05.
(K) Cell-autonomous effects of exogenous thiosulfate on MTT activity during the reperfusion phase following simulated IRI in Hepa1-6 cells ± SQR KD. Asterisk
indicates the significance of the difference in the indicated group ± thiosulfate treatment; hash mark indicates the significance of the difference between control
and SQR KD within a given treatment group; */#p < 0.05.
All error bars SEM. See also Figure S5.(Figure S6E), but RNAi KD specifically of CBS-1 significantly
decreased eat-2 mediated lifespan extension, whereas overex-
pression of CBS-1 significantly extended median lifespan of
WT N2 controls (Figure 6F).Finally, DR-mediated extension of chronological lifespan in
the yeast S. cerevisiae can be accomplished by reducing
glucose in the growth media from 2% to 0.5% (Figure 6G) (Wu
et al., 2013). Under these conditions, H2S production from theCell 160, 132–144, January 15, 2015 ª2015 Elsevier Inc. 139
Figure 6. Increased Endogenous H2S Production in Diet-Induced Longevity Extension Models Crosses Evolutionary Boundaries
(A and B) H2S production capacity of liver and kidney extracts frommice with AL access to complete or MetR diets as indicated for 4 months (A) and in mice with
AL, every-other-day (EOD) fasting, or 20%–30% restricted diets for 6 weeks (B). Each circle represents H2S production from an individual animal, normalized for
extract protein content.
(C) H2S production capacity of whole-fly lysates normalized for protein content from populations subjected to the indicated dietary amino acid (AA) and Met
concentrations. Maximal H2S production capacity correlated with the optimal diet for longevity extension (0.4 3 AA with 0.15 mM Met) (Lee et al., 2014).
(D) H2S production capacity of N2 and eat-2 whole-worm lysates in quadruplicate.
(E) Lifespan of N2 and eat-2 worms subjected to RNAi-mediated KD of the TSP genes cbs-1 or cbl-1 as indicated.
(F) Lifespan analysis of WT or transgenic worms overexpressing CBS-1.
(G) Chronological lifespan of budding yeast grown in 2% or 0.5% glucose as indicated.
(H) H2S production in yeast cultures grown in 2%or 0.5%glucose as detected by black lead sulfide accumulation on lead acetate papers inserted into the caps of
the growth flasks and removed at the indicated time point.
(I) Schematic of transmethylation, TSP, and H2S production in budding yeast.
(J) H2S production in WT and sulfur assimilatory pathway mutant strains grown in 2% or 0.5% glucose for the indicated time.
(K) H2S production in the met14 sulfur assimilatory mutant grown in 0.5% glucose and the indicated relative amount of Met or Cys.
(L) Chronological lifespan in 2% glucose ± H2S donors NaHS and GYY4137 added during early culture growth at indicated time points (arrows).
All error bars SEM. See also Figure S6.glucose-restricted cultures was detected within 24–48 hr and
continued to increase for up to 96 hr in three different yeast
strains (Figure 6H; Figures S6F and S6G). As the majority of
H2S production in yeast occurs via an assimilatory pathway
not present in metazoans in which extracellular sulfate is con-
verted to sulfide by the combined enzymatic activities of
MET14, MET16, and MET5/10 (Figure 6I), we next asked if140 Cell 160, 132–144, January 15, 2015 ª2015 Elsevier Inc.increased H2S upon DR occurred through this assimilatory
pathway or the conserved TSP pathway in yeast. Deletion of
MET5, 14, or 16 resulted in inhibition of H2S production under
2.0%glucose but did not block H2S induction (Figure 6J) or chro-
nological longevity extension (Figure S6H) upon glucose restric-
tion. To further confirm Met and/or Cys, rather than inorganic
sulfur, as the primary source of increased H2S under conditions
Figure 7. Model of DR-Mediated Benefits through Increased H2S
Production
DR regimens leading to extended longevity across evolutionary boundaries
include PR, SAA restriction, and Cys restriction, leading to increased TSP
activity via CGL and/or CBS family members, and increased endogenous H2S
production. Specific SAA addition, increased activity of the nutrient/energy
sensing kinase, mechanistic target of rapamycin (mTOR), or the pharmaco-
logical agent, PAG, can block TSP upregulation and H2S production. H2S can
readily diffuse through tissues and has pleiotropic, overlapping beneficial
effects on the cellular, tissue, and organismal levels with the potential to
contribute to stress resistance and longevity benefits of DR.upon glucose restriction, we examined H2S production in a
Dmet14 line lacking a functional assimilatory pathway, with
differing concentrations of Met and Cys in the media. Complete
deprivation of either Met or Cys resulted in reduced H2S produc-
tion (Figure 6K). Thus, under conditions of glucose restriction,
H2S is produced from SAAs via the TSP. Because TSP-deficient
CGL/STR1 and CBS/STR4 deletion strains grow abnormally in
culture, it was not possible to test their requirement for increased
H2S production or extended chronological longevity under low-
glucose conditions. However, exogenous H2S donors NaHS
and GYY4137 added early after inoculation were sufficient to
significantly increase chronological lifespan (Figure 6L).
DISCUSSION
H2S as Unifying Mechanism of DR Regimens and
Benefits
As presented in the model in Figure 7, multiple DR regimens,
including total food restriction, PR and SAA restriction/MetR,
confer overlapping functional benefits in a number of diverse or-
ganisms from yeast (Johnson and Johnson, 2014) to worms
(Cabreiro et al., 2013) to flies (Grandison et al., 2009; Troen
et al., 2007) to rodents (Miller et al., 2005; Orentreich et al.,
1993). In each of these experimental organisms, we found
an increase in TSP-mediated H2S production upon application
of species-appropriate longevity regimens, ranging from EOD
and MetR in mice to glucose restriction in yeast. Furthermore,
in rodents and worms we demonstrated that genetic repression
of TSP components blocked DR benefits, whereas overexpres-
sion could mimic benefits in the absence of any dietary interven-
tion. In yeast, we found the TSP, rather than the assimilatory
pathway, to be a major source of H2S production upon glucose
restriction. Although future studies are required to directly
demonstrate the necessity of H2S production for various DR
benefits, our data demonstrate increased H2S production via
the TSP is an evolutionarily conserved response to DR from
yeast to mammals with the potential to mediate multiple DR ben-
efits including stress resistance and longevity. We note that the
ability of SAA restriction to confer benefits in no way rules out
other dietary triggers or downstream mechanisms of DR
benefits, and that future studies will be required to determine ifbenefits attributed to different DR regimens, including Trp re-
striction, impact the TSP or H2S production.
Regulation of TSP Gene Expression and H2S Production
Cys deprivation triggers increased TSP gene expression
possibly via the integrated stress response through GCN2 acti-
vation, eIF2a phosphorylation, and ATF4 stabilization (Lee
et al., 2008). We confirmed the ability of DR to increase hepatic
CGL expression in vivo, and Cys or NAC addback to block this
induction. Whether or not GCN2 is required for this remains to
be determined; however, our data suggest a role for mTORC1
in CGL regulation, because constitutive mTORC1 expression in
the TSC1KO livers blocked diet-induced CGL expression.
Because the logic underlying TSP activation upon Cys depri-
vation is presumably to increase Cys biosynthesis, the notion
that Cys degradation into H2S increases when Cys concentra-
tions are limiting is potentially counterintuitive. However, the
in vivo source and identity of substrates for CGL or CBS-derived
H2S uponDR are not known. Free Cys released upon autophagy,
rather than that produced de novo by TSP, could be a major fuel
source for H2S production. Interestingly, the benefits of MetR on
longevity in yeast require autophagy (Ruckenstuhl et al., 2014),
but whether autophagy plays a role in H2S production remains
to be determined.
Potential Mechanisms of H2S Action in DR
By what mechanism(s) could endogenous H2S give rise to pleio-
tropic DR benefits? We found that resistance to simulated IRI
in vitro required the mitochondrial ETC component SQR. The
SQR is thought to be of eubacterial origin and conserved from
the early evolution of eukaryotes in an anoxic and sulfidic world
(Theissen et al., 2003). H2S could interact with SQR to lend pro-
tection against ischemia by donating electrons to the ETC via co-
enzymeQ, thuspotentially serving as a sourceof electronsduring
ischemia. Interestingly, thiosulfate generated as a product of H2S
oxidation via SQR can undergo further chemical modification in
a thioredoxin-reductase-dependent reaction using glutathione
to produce sulfite and/or sulfate (Olson et al., 2013), which are
used in some unicellular organisms as terminal electron accep-
tors for ATP production instead of oxygen, resulting in H2S
generation (Muyzer and Stams, 2008). Whether this can occur
inmammalian cells remains tobeexplored; however, theaddition
of thiosulfate tohypoxicmammalian tissues results in theproduc-
tion of H2S by unknown mechanisms (Olson et al., 2013).
Vasodilatory effects of H2S could contribute to healthspan and
lifespan extension in mammals by counteracting atheroscle-
rosis, hypertension, and trauma. Exogenous H2S protects the
vasculature from oxidative damage (Yan et al., 2006), whereas
a lack of CGL and/or endogenous H2S production leads to hy-
pertension (Yang et al., 2008). Fasting and PR protect the vascu-
lature against intimal hyperplasia as a result of carotid focal
stenosis (Mauro et al., 2014), correlating with increased H2S pro-
duction capacity upon DR in the carotid artery in vivo and
vascular smooth muscle cells in vitro. Fasting protects the brain
against IRI in rat models of transient middle cerebral artery oc-
clusion (Varendi et al., 2014) and increased H2S production ca-
pacity in mouse brain (Figure S6D). Future studies are required
to address the specific role of increased TSP activity and H2SCell 160, 132–144, January 15, 2015 ª2015 Elsevier Inc. 141
production in DR-mediated effects on the vasculature and other
organ systems.
Clinical Significance
The use of exogenous H2S as a DR mimetic is appealing for ap-
plications in which patient compliancewith restricted food intake
is an issue, but nonetheless remains challenging due to the short
half-life of the gas in vivo and risks of toxicity at high levels. Mod-
ulation of endogenous H2S production by diet offers advantages
in terms of safety and continuous delivery in planned applica-
tions with brief duration, for example, in the context of precondi-
tioning prior to elective surgery. In this context, H2S may have
pleiotropic advantages on surgical outcome, including vasodila-
tory and anti-inflammatory effects on the systemic level, as well
as benefits against ischemic injury that may arise as part of the
procedure itself or an unintended complication including heart
attack or stroke.
Conclusions
H2S was in vogue for centuries past as a cure-all before being
viewed as a poisonous toxin with little or no acceptable level of
exposure. Recently, H2S has re-emerged as a potential thera-
peutic agent addressing numerous health issues (Zhang et al.,
2013). Here, we identified DR as a trigger of increased endoge-
nous H2S production, and H2S as a molecular mediator of pleio-
tropic DR benefits including longevity and stress resistance.
These findings have broad implications for our basic under-
standing of DR and its potential clinical applications.
EXPERIMENTAL PROCEDURES
Additional details are provided in the Extended Experimental Procedures.
Mice
All experiments were performed with the approval of the Harvard Medical Area
Animal Care andUse Committee (IACUC). Eight- to 10-week-oldmale B6D2F1
hybrids (The Jackson Laboratory) were used for all experiments unless other-
wise indicated. Male and female NRF2 KO and littermate controls on a mixed
129/C57BL/6 background (Martin et al., 1998), LTsc1KO and littermate
controls on a C57BL/6 background (Harputlugil et al., 2014), and CGLKO




Mice were given AL access to food and water unless otherwise indicated.
Experimental diets were based on Research Diets D12450B with approxi-
mately 18% of calories from protein (hydrolyzed casein or individual crystalline
amino acids [Ajinomoto] in the proportions present in casein), 10% from fat
and 72% from carbohydrate. AL food intake was monitored for several days
and used to calculate 50% DR. Mice were fed daily with fresh food between
6 and 7 p.m.
Pharmacological
NAC (600 mg/kg/day total in food and drinking water) and VitC&E (1,000 and
250 mg/kg/day, respectively, in food and drinking water) supplementation
was halted 16–24 hr prior to organ harvest and/or induction of IRI. NaHS
(1 mM) or GYY4137 (260 mM final) was delivered in the drinking water; PAG
(10 mg/kg) and NaHS (3–5 mg/kg) were administered by IP injection.
Adenoviral-Mediated Gene Delivery
CGL was overexpressed by intravenous injection of 1010 plaque-forming units
of Ad-CMV-CGL (ADV-256305) or control Ad-CMV Null virus (Vector Biolabs)
7 days prior to hepatic IRI.142 Cell 160, 132–144, January 15, 2015 ª2015 Elsevier Inc.Cells
In vitro DR was performed in mouse Hepa1-6 cells, primary hepatocytes, or
primary aortic smooth muscle cells by incubating in DMEM lacking Met and
Cys (Invitrogen) with 10% dialyzed FBS for up to 20 hr.
Ischemia Reperfusion Models
In Vivo
Warm hepatic or renal IRI was induced, and damage was assessed as previ-
ously described (Peng et al., 2012). ALT, AST, and/or LDH values were normal-
ized to the experimental control; usually the WT group fed a complete diet AL,
for each time point (3, 24 hr postreperfusion) and combined into a single value
per animal.
In Vitro
For simulated ischemia, growth or preconditioning media was replaced with
saline to mimic nutrient/energy deprivation and placed in an airtight chamber
flushed with nitrogen gas at 37C for 4 hr. Saline supernatant was removed af-
ter simulated ischemia for LDH measurement. Reperfusion was simulated by
adding back fresh complete DMEM-12320 (Invitrogen) containing 0.5 mg/ml
MTT under normoxia at 37C for an additional 3–4 hr.
Metabolic Parameters
Body composition was determined with an Echo MRI. Blood glucose was
measured with an Easy Step Glucometer (Home Aide Diagnostics), serum tri-
glycerides with a Serum Triglyceride Determination Kit (Sigma), liver RONS
and GSH from left hepatic lobes normalized by wet weight using OxiSelect
In Vitro Green Fluorescence ROS/RNS Assay Kit (Cell Biolabs) and the fluori-
metric Glutathione Assay Kit (Sigma), and liver metabolites via mass spec-
trometry and normalized to total protein content. Peroxisome b-oxidation of
lipids was performed on freshly harvested liver (Hu et al., 2005; Lazarow,
1981).
mRNA and Protein Analysis
Total RNA was isolated from tissues and cells using miRNeasy Mini Kit
(QIAGEN) and cDNA synthesized by random hexamer priming with the Verso
cDNA kit (Thermo Scientific). qRT-PCR was performed with SYBR green dye
(Lonza) and TaqPro DNA polymerase (Denville). Fold changes were calculated
by the DDCt method using Hprt and/or Rpl13 as standards and normalized to
the experimental WT AL control. Protein expression was analyzed in tissues
homogenized in passive lysis buffer (Promega), separated by SDS-PAGE,
transferred to PVDF membrane (Whatman), and blotted for CGL (ab151769
Abcam), CBS (ab135626 Abcam), or actin (13E5 Cell Signaling) followed by
HPRT-conjugated secondary anti-rabbit antibody (Dako).
H2S Measurements
Lead Sulfide Method
H2S production capacity was measured in 100 mg fresh tissue or 100–300 mg
freeze-thaw homogenate in passive lysis buffer (Promega) of tissues, flies or
worms, in PBS supplemented with 10 mM Cys and 10 mM-6 mM PLP. A
lead acetate H2S detection paper (Sigma; or made by soaking blotting paper
[VWR] in 20 mM lead acetate [Sigma] and then vacuum drying) was placed
above the liquid phase in a closed container (microcentrifuge tube or covered
96-well plate) and incubated 2–5 hr at 37C until lead sulfide darkening of the
paper occurred. In live Hepa1-6 cells in 96-well plates, growth media was sup-
plemented with 10 mM Cys and 10 mM PLP, and a lead acetate paper placed
over the plate for 2–24 hr of further incubation in a CO2 incubator at 37
C. In live
yeast culture, lead acetate papers were placed above liquid cultures at the
time of inoculation.
Sulfide Probe Method
Amicrosulfide ion electrode probe (Lazar Research Laboratories) and volt me-
ter (Jenco) were used to measure H2S production capacity in extracts in vitro
and endogenous H2S concentrations in liver in vivo upon direct insertion into
median and left lobes of anesthetized mice prior to sacrifice.
Fly Conditions
D.melanogasterweremaintainedasdescribedpreviously (Leeet al., 2014). Flies
used in theH2S production capacity assaywere held on the designated diet and
transferred to fresh vials without anesthesia every 3 days until 18 days of age.
Worm Conditions
N2 and DA1116 (eat-2(ad1116) II.) strains were grown following standard pro-
cedures, and all lifespan experiments were carried out as previously described
(Mair et al., 2011). RNAi clones were from the Ahringer RNAi library. CBS trans-
genic strains overexpressing the cbs-1 isoform a (ZC373.1a) from the ubiqui-
tous sur-5 promoter and unc-54 30 UTR were generated by microinjection into
gonads of young adult hermaphrodites.
Yeast Conditions
Experiments were carried out in WT strains BY4742 (MATa his3D1 leu2D0
lys2D0 ura3D0), W303 (MATa leu2-3,112 trp1-1 can1-100 ura3-1 ade2-1
his3-11,15), and DBY746 (MATa leu2-3, 112 his3D1 trp1-289 ura 3-52 GAL+).
Met deletion strains in BY4742 (met5, met14, and met16) were purchased
fromEUROSCARF. For chronological aging experiments, cellswere inoculated
to an OD600 of 0.05 and grown at 28
C in SCD media, and cell survival was
determined by clonogenicity at the given time points in at least three indepen-
dent cultures, and values were normalized to survival on day 1. Longevity ef-
fects of exogenous H2S were tested by adding 100 mM GYY4137 (in DMSO)
to BY4742 cultures at the time of inoculation and 5 mM NaHS at 6, 24, and
48 hr after inoculation, with DMSO-treated BY4742 as a control.
Statistical Analyses
Data are displayed asmeans ± SEM, and statistical significance was assessed
inGraphPad Prism using Student’s t tests to compare values and one-sample t
test to compare means to a hypothetical value of 1 or 100 when data were
normalized to the average value of the control group. A p value of 0.05 or
less was deemed statistically significant.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures and
six figures and can be found with this article online at http://dx.doi.org/10.
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